Admission Date:  [**2155-1-27**]              Discharge Date:   [**2155-1-31**]

Date of Birth:  [**2108-5-5**]             Sex:   M

Service: MEDICINE

Allergies:
Patient recorded as having No Known Allergies to Drugs

Attending:[**First Name3 (LF) 905**]
Chief Complaint:
Wheezing

Major Surgical or Invasive Procedure:
none


History of Present Illness:
   The patient is a 46 year old male with PMH of asthma and
morbid obesity, who presented to an OSH on [**2155-1-27**] with
complaint of wheezing and DOE x 2 days.  Patient reports onset
of SOB, wheezing, and fevers on [**1-25**].  His PCP had prescribed
amoxicillin, but patient denied any improvement in his symptoms.
 On presentation to the OSH, the patient was noted to be in
respiratory distress, with a room air O2 sat of 91%. ABG was
noted to be 7.34/53/69.  He was placed on a 50% face mask, and
he was administered prednisone, Levofloxacin, and
bronchodilators. He was transferred to [**Hospital1 18**] for further
management.

Past Medical History:
1. Asthma- no history of intubation. Last flare ~7 years ago.
2. HTN
3. Morbid obesity

Social History:
The patient lives with his wife, children, and mother-in-law.
[**Name (NI) **] quit smoking on [**2154-1-25**]. He smoked 1.5 packs per day x 20-30
years.  He drinks alcohol occasionally.  Denies illicit drug
use.

Family History:
NC

Physical Exam:
VS: T: 100.4   BP: 154/64  HR: 101  RR: 20  O2 sat: 95% on 50%
face mask
General: Obese male lying in bed in mild respiratory distress.
Patient is able to speak in full sentences
HEENT: MMM. Oropharynx clear.
Neck: Supple. No LAD.
CVS: Distant heart sounds, tachy. No murmurs appreciated.
Lungs: Diffuse insp and exp wheezes throughout, moderate air
movement.
Abd: Obese, soft, NT, +BS.
Extr: No c/c/e. Warm.

Pertinent Results:
WBC  Hgb  Hct MCV  Plt Ct
10.5 14.1 40.5 91   293

Neuts  Bands  Lymphs Monos Eos
78.4*   16.9* 4.0    0.3   0.3


Glucose UreaN Creat Na  K   Cl   HCO3
113*     12    0.8  138 3.7 100  30*

Calcium  Phos  Mg
  8.6     3.7  2.2

UA ([**1-28**]):
Color Appear Sp [**Last Name (un) **]
Straw Clear   1.025

Blood Nitrite Protein Glucose Ketone Bilirub Urobiln  pH  Leuks
 NEG  NEG      TR      NEG     NEG    NEG     NEG     6.5  NEG


Micro:
[**1-27**]: Influenza A DFA: POS

Sputum ([**1-27**])

   GRAM STAIN (Final [**2155-1-28**]):
      [**10-28**] PMNs and <10 epithelial cells/100X field.
      2+   (1-5 per 1000X FIELD):   MULTIPLE ORGANISMS
CONSISTENT WITH
                                    OROPHARYNGEAL FLORA.

   RESPIRATORY CULTURE (Pending):

Blood cx x 2 ([**1-28**]): pending
Urine cx ([**1-28**]): pending

Radiology:
CHEST (PORTABLE AP)  [**2155-1-27**] 10:54 AM
Large size habitus of patient, but no evidence of CHF or acute
infiltrates on portable single view examination.

CHEST (PORTABLE AP)  [**2155-1-28**] 6:06 AM
Hypoventilation involving the lower lobes. No evidence of active
congestion or infiltration. No evidence of pleural effusion or
pneumothoraces.

EKG:
Sinus tach 107.  Nl int, nl axis. Q III. No ST/TW changes.

Brief Hospital Course:
46 year old male with PMH of asthma, HTN, and morbid obesity,
admitted to MICU on [**1-27**] with wheezing/SOB.

1) Asthma exacerbation/influenza A: The patient was admitted to
the MICU for management of his respiratory distress.  He was
placed on BiPAP overnight on [**1-27**]. He was treated for an asthma
exacerbation with steroids and bronchodilators.  He continued on
Levofloxacin for treatment of tracheobronchitis. On [**1-28**], the
patient spiked a temperature of 102.4  His nasopharyngeal
aspirate came back positive for influenza A.  The patient was
maintained on continous nebulizers, which have been tapered to q
4 hours.  Since the patient did not tolerate BiPAP, so he was
placed on nasal CPAP (12-15 cm H2O) for likely obstructive sleep
apnea.  In addition, the patient was administered Wellbutrin and
a nicotine patch to assist with smoking cessation.  Given
improvement in his respiratory status, the patient was
transferred to the medical floor.

2) Smoking cessation: The patient was srtarted on Wellbutrin and
Nictoine patch.

3) OSA: He was placed on nocturnal CPAP 12-15 cm H2O with a
nasal mask. Patient's PCP (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **]) has been contact[**Name (NI) **]
and outpatient sleep study was recommended.

4) HTN: Captopril was titrated as necessary and the dose was
converted to Lisinopril at the time of discharge.

5) Steroid-induced hyperglycemia. Glycemic control was
maintained with RISS.

6) FEN: Low Na diet.


Medications on Admission:
Medications on admission:
Azmacort
Albuterol
Avalade
Amoxicillin
Guiafenescin

Discharge Medications:
1. Fexofenadine HCl 60 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
Disp:*60 Capsule(s)* Refills:*0*
2. Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H (every
24 hours) for 6 days.
Disp:*6 Tablet(s)* Refills:*0*
3. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.) Sig:
One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours)
for 2 weeks.
Disp:*14 Tablet, Delayed Release (E.C.)(s)* Refills:*0*
4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
Disp:*60 Capsule(s)* Refills:*2*
5. Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation
Q4H (every 4 hours).
6. Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation
Q4H (every 4 hours).
7. Bupropion HCl 150 mg Tablet Sustained Release Sig: One (1)
Tablet Sustained Release PO QD ().
Disp:*30 Tablet Sustained Release(s)* Refills:*2*
8. Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
Disp:*30 Tablet(s)* Refills:*2*
9. Montelukast Sodium 10 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
Disp:*30 Tablet(s)* Refills:*2*
10. Fluticasone Propionate 110 mcg/Actuation Aerosol Sig: Four
(4) Puff Inhalation [**Hospital1 **] (2 times a day).
Disp:*1 inhaler* Refills:*2*
11. Lisinopril 20 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*
12. Nicotine 14 mg/24 hr Patch 24HR Sig: One (1) Patch 24HR
Transdermal DAILY (Daily).
Disp:*7 Patch 24HR(s)* Refills:*0*
13. Prednisone 20 mg Tablet Sig: Three (3) Tablet PO once a day
for 2 days: 0n [**2-1**] and [**2-2**].
Disp:*6 Tablet(s)* Refills:*0*
14. Prednisone 50 mg Tablet Sig: One (1) Tablet PO once a day
for 2 days: on [**2-3**] and [**2-4**].
Disp:*2 Tablet(s)* Refills:*0*
15. Prednisone 20 mg Tablet Sig: Two (2) Tablet PO once a day
for 2 days: on [**2-5**] and [**2-6**].
Disp:*4 Tablet(s)* Refills:*0*
16. Prednisone 10 mg Tablet Sig: Three (3) Tablet PO once a day
for 2 days: [**2-7**] and [**2-8**].
Disp:*6 Tablet(s)* Refills:*0*
17. Prednisone 20 mg Tablet Sig: One (1) Tablet PO once a day
for 2 days: [**2-9**] and [**2-10**].
Disp:*2 Tablet(s)* Refills:*0*
18. Prednisone 10 mg Tablet Sig: One (1) Tablet PO once a day
for 2 days: [**2-11**] and [**2-12**].
Disp:*2 Tablet(s)* Refills:*0*
19. Respitory Therapy
please supply 1 CPAP machine with all accessories necessary for
daily overnight use.
20. oxygen please supply continuous oxygen @ 2L nasal canula.
*
Pt is hypoxic at rest 89% (RA) and desaturates to <88% (RA) on
ambulation.
21. CPAP settings please set CPAP @ 12 cm and 10 L/minute 02
in-line for nightly use.


Discharge Disposition:
Home With Service

Facility:
Respiratory Solutions

Discharge Diagnosis:
1. asthma exerbation
2. tracheobroncitis
3. obstructive sleep apnea
4. hypetension


Discharge Condition:
good

Discharge Instructions:
1. call 911 or go to the nearest ER if you experience increased
shortness of breath, chest pain, fevers, chills, or feel unwell.


Followup Instructions:
1. please call your primary care physician and pulmonologist,
Dr. [**Last Name (STitle) **], to follow up on your recent admission in the next
1-2 weeks @ [**Telephone/Fax (1) 693**].
2. You are schedule to see Dr. [**First Name (STitle) **] on [**Last Name (LF) 2974**], [**4-11**] at
2:00 pm for sleep study @ 2:00 pm on [**Location (un) **] [**Hospital Ward Name 23**] Center;
call ([**Telephone/Fax (1) 9525**] for questions.


                             [**Name6 (MD) 251**] [**Name8 (MD) **] MD [**MD Number(1) 910**]

Completed by:[**2155-6-1**]